SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Financing Biomedical Innovation
16 references·0 citing·44 second hopsampled
Financing Biomedical Innovation (2022)Financing Biomedical InnovationInnovation in the pharmaceutical industry: New estimates of R&D costs (2016)Innovation in the pharmaceuti…Does Going Public Affect Innovation? (2015)Does Going Public Affect Inno…Clinical development success rates for investigational drugs (2014)Clinical development success …Diagnosing the decline in pharmaceutical R&D efficiency (2012)Diagnosing the decline in pha…Text-Based Network Industries and Endogenous Product Differentiation (2011)Text-Based Network Industries…Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs (2010)Trends in Risks Associated Wi…The Financing of R&D and Innovation (2010)The Financing of R&D and Inno…Product Market Synergies and Competition in Mergers and Acquisitions: A Text-Based Analysis (2010)Product Market Synergies and …Financing Innovation and Growth: Cash Flow, External Equity, and the 1990s R&D Boom (2009)Financing Innovation and Grow…Characteristics, Contracts, and Actions: Evidence from Venture Capitalist Analyses (2004)Characteristics, Contracts, a…The product market and the market for “ideas”: commercialization strategies for technology entrepreneurs (2003)The product market and the ma…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Assessing the Contribution of Venture Capital to Innovation (2000)Assessing the Contribution of…Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)Scale, Scope, and Spillovers:…Collateral and Rationing: Sorting Equilibria in Monopolistic and Competitive Credit Markets (1987)Collateral and Rationing: Sor…Corporate financing and investment decisions when firms have information that investors do not have (1984)Corporate financing and inves…Can the pharmaceutical industry reduce attrition rates? (2004)A Comprehensive Map of FDA-Approved Pharmaceutical Products (2018)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Lessons from 60 years of pharmaceutical innovation (2009)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Are Ideas Getting Harder to Find? (2020)Generating Theory by Abduction (2021)Invention and Economic Growth (1966)Issues in Assessing the Contribution of Research and Development to Productivity Growth (1979)The Dynamics of Productivity in the Telecommunications Equipment Industry (1992)Law, Finance, and Economic Growth in China (2003)The dynamics of crowdfunding: An exploratory study (2013)Technological Innovation, Resource Allocation, and Growth* (2017)Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment Equations (1991)Another look at the instrumental variable estimation of error-components models (1995)Initial conditions and moment restrictions in dynamic panel data models (1998)Financial development and innovation: Cross-country evidence (2013)Financing Innovation: Evidence from R&D Grants (2017)Cost of innovation in the pharmaceutical industry (1991)Stocks, bonds, bills, and inflation yearbook (1993)Risks in new drug development: Approval success rates for investigational drugs (2001)Cost-Effectiveness in Health and Medicine (1996)Essential medicines for universal health coverage (2016)The High Cost of Prescription Drugs in the United States (2016)The Strength of Weak Ties (1973)Management ownership and market valuation (1988)The Modern Industrial Revolution, Exit, and the Failure of Internal Control Systems (1993)Corporate social responsibility and stakeholder value maximization: Evidence from mergers (2013)Measuring Economic Policy Uncertainty* (2016)Stability in Competition (1929)Industry costs of equity (1997)When Is a Liability Not a Liability? Textual Analysis, Dictionaries, and 10‐Ks (2011)Textual Analysis in Accounting and Finance: A Survey (2016)Text as Data (2019)Artificial Intelligence, Firm Growth, and Industry Concentration (2020)The Market for "Lemons": Quality Uncertainty and the Market Mechanism (1970)Theory of the firm: Managerial behavior, agency costs and ownership structure (1976)Determinants of corporate borrowing (1977)The Capital Structure Puzzle (1984)A Survey of Corporate Governance (1997)Information asymmetry, corporate disclosure, and the capital markets: A review of the empirical disclosure literature (2001)Corporate social responsibility and access to finance (2013)Mission-oriented innovation policies: challenges and opportunities (2018)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 1984Corporate financing and investment decisions when firms have information that investors do not have18,936 cited
  • 2003The price of innovation: new estimates of drug development costs4,312 cited
  • 2016Innovation in the pharmaceutical industry: New estimates of R&D costs3,621 cited
  • 2014Clinical development success rates for investigational drugs2,616 cited
  • 2011Text-Based Network Industries and Endogenous Product Differentiation2,187 cited
  • 2000Assessing the Contribution of Venture Capital to Innovation2,098 cited
  • 2012Diagnosing the decline in pharmaceutical R&D efficiency2,039 cited
  • 2009Financing Innovation and Growth: Cash Flow, External Equity, and the 1990s R&D Boom1,858 cited
  • 2010The Financing of R&D and Innovation1,796 cited
  • 2010Product Market Synergies and Competition in Mergers and Acquisitions: A Text-Based Analysis1,498 cited
  • 1996Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery1,389 cited
  • 2003The product market and the market for “ideas”: commercialization strategies for technology entrepreneurs1,297 cited
  • 2004Characteristics, Contracts, and Actions: Evidence from Venture Capitalist Analyses1,220 cited
  • 1987Collateral and Rationing: Sorting Equilibria in Monopolistic and Competitive Credit Markets966 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2015Does Going Public Affect Innovation?847 cited
  • 2010Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs847 cited
  • Cited by

    No citing works inside the corpus for this window.